387 related articles for article (PubMed ID: 16107180)
21. Psychoses in the elderly: a spectrum of disorders.
Targum SD; Abbott JL
J Clin Psychiatry; 1999; 60 Suppl 8():4-10. PubMed ID: 10335666
[TBL] [Abstract][Full Text] [Related]
22. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
[TBL] [Abstract][Full Text] [Related]
23. Alcohol and substance abuse in panic disorder.
Marshall JR
J Clin Psychiatry; 1997; 58 Suppl 2():46-9; discussion 49-50. PubMed ID: 9078994
[TBL] [Abstract][Full Text] [Related]
24. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
26. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
Kim JH; Kim D; Park SH; Lee HB; Chung EK
J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
[TBL] [Abstract][Full Text] [Related]
27. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
[TBL] [Abstract][Full Text] [Related]
28. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
29. Current research on co-occurring substance-use disorder in schizophrenia.
Drake RE; Green AI
Schizophr Bull; 2006 Oct; 32(4):616-7. PubMed ID: 16896056
[No Abstract] [Full Text] [Related]
30. Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales.
Frisher M; Collins J; Millson D; Crome I; Croft P
J Epidemiol Community Health; 2004 Dec; 58(12):1036-41. PubMed ID: 15547069
[TBL] [Abstract][Full Text] [Related]
31. Psychiatric comorbidity in forensic psychiatry.
Palijan TZ; Muzinić L; Radeljak S
Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, etiology, diagnosis, and treatment of schizophrenia.
Ryan PM
Am J Hosp Pharm; 1991 Jun; 48(6):1271-80. PubMed ID: 1677528
[TBL] [Abstract][Full Text] [Related]
33. Olanzapine and the new generation of antipsychotic agents: patterns of use.
Glazer WM
J Clin Psychiatry; 1997; 58 Suppl 10():18-21. PubMed ID: 9265912
[TBL] [Abstract][Full Text] [Related]
34. Clozapine for substance-abusing schizophrenic patients.
Tsuang JW; Eckman TE; Shaner A; Marder SR
Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
[No Abstract] [Full Text] [Related]
35. Schizophrenia and comorbid metabolic disorders.
Henderson DC
J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
[TBL] [Abstract][Full Text] [Related]
36. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
37. [Schizophrenia and addiction. A frequent psychiatric dual diagnosis].
Wettig J
MMW Fortschr Med; 2001 May; 143 Suppl 2():67-70. PubMed ID: 11434263
[TBL] [Abstract][Full Text] [Related]
38. Criminality in men with major mental disorder with and without comorbid substance abuse.
Modestin J; Wuermle O
Psychiatry Clin Neurosci; 2005 Feb; 59(1):25-9. PubMed ID: 15679536
[TBL] [Abstract][Full Text] [Related]
39. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
40. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
